Merck cancer shot gets FDA approval: What to know

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's what we know.
The Malaysian Reserve

TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen

TREMFYA® offers the flexibility of self-administration from the start of treatment, building on the prior approval of subcutaneous induction in Crohn's ...
Yahoo Finance

FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for ...

KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute RAHWAY, N.J., September 19, ...
urologytimes

FDA approves pembrolizumab for subcutaneous injection for solid tumors

The FDA approved subcutaneous pembrolizumab and berahyaluronidase alfa-pmph for solid tumors in patients 12 years or older. Recommended dosages are 395 mg/4800 U every 3 weeks or 790 mg/9600 U every 6 ...
The Globe and Mail

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage ...
Healthline

Where to Inject Ozempic

Ozempic (semaglutide) is injected once weekly under the skin of your abdomen, upper arm, or thigh. Your doctor will show you how to do this before your first dose. To prevent skin issues, rotate your ...
Medical News Today

Zepbound vs. Ozempic: How they compare

Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...
The Globe and Mail

Cardinal Energy Ltd. Announces Monthly Dividend for September and Commencement of Steam Injection into the Reford Thermal Project

Calgary, Alberta--(Newsfile Corp. - September 8, 2025) - Cardinal Energy Ltd. (TSX: CJ) ("Cardinal" or the "Company") confirms that our September dividend of $0.06 per common share will be paid on ...
ascopubs.org

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...
Healio

FDA approves Leqembi at-home subcutaneous injection in early Alzheimer’s

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...
McKnight's Long-Term Care News

FDA OKs subcutaneous lecanemab injection for maintenance dosing for early Alzheimer’s

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...